Menu Menu


/ News
Wednesday, 17th August 2022 | 9,805 veterinary jobs online | 79 people actively seeking work | 5,216 practices registered

Veterinary Industry News

Send us your news

Animalcare’s Buprecare® Back In Stock

9 months ago

8th November, 2021 17h24


York – November 2021:  Animalcare has announced that Buprecare®, its multidose buprenorphine analgesic for cats and dogs, is back in stock at the wholesalers following a move to a new manufacturing site. Buprecare is indicated for post-operative analgesia and the potentiation of the sedative effects of centrally-acting agents in dogs, as well as post-operative analgesia in cats.  It is presented in a 10 ml multi-use bottle.

Commenting, Animalcare Product Manager Eleanor Workman Wright said: "Buprenorphine is a potent, high affinity, synthetic opioid.  It plays a central role in many practice anaesthesia protocols so we are delighted to announce that it is back in stock. Buprecare is part of Animalcare’s extensive anaesthetic toolkit, which offers options for analgesia, sedation, gaseous anaesthesia and recovery."

Practices are asked to contact their Animalcare Territory Manager or contact Animalcare’s head office on 01904 487687 for further information and pricing. 


About Animalcare

Animalcare is a sustainable and passionate organisation committed to leading in animal health through innovative and trusted products and services to support the veterinary profession. It has recently launched its first novel product - Daxocox®. It is the first weekly oral NSAID and achieves not only significant improvement in the clinical signs associated with the pain of osteoarthritis (OA) in dogs, but may also help to reduce the risk of OA breakthrough pain.  


Follow Animalcare at:

For further information:

Rebecca George, George PR

Tel: 01449 737281/07974 161108


More from Animalcare